INCY
Incyte Corporation · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom +6.1% · netto nieuwe posities 0.0% · formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2024
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 433.49K | $48.73M | n/a | −2 |
| Q2 2026 | 154 | 0 | 131.73M | $14.93B | +4 | −5 |
| Q1 2026 | 158 | +1 | 132.61M | $12.47B | +5 | −5 |
| Q4 2025 | 156 | -1 | 139.13M | $13.74B | +1 | −1 |
| Q3 2025 | 24 | 0 | 89.63M | $7.60B | n/a | −1 |
| Q2 2025 | 22 | +1 | 88.20M | $6.01B | +1 | n/a |
| Q1 2025 | 18 | -1 | 44.33M | $2.68B | n/a | −1 |
| Q4 2024 | 19 | +1 | 43.85M | $3.03B | +1 | n/a |
| Q3 2024 | 17 | 0 | 35.50M | $2.35B | +1 | −1 |
| Q2 2024 | 17 | n/a | 33.47M | $2.03B | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 15.28M | 0.0% | $1.01B | 0.6% | ▼ Trim | 2 | SEC ↗ |
| 2 | Renaissance Technologies ✦ | 4.50M | -13.8% | $297.42M | 0.4% | ▼ Trim | 2 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passief) | 3.94M | -2.7% | $259.33M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 4 | AQR Capital Management ✦ | 2.70M | +1.5% | $178.58M | 0.2% | ▲ Add | 2 | SEC ↗ ×3 |
| 5 | Point72 Asset Management ✦ | 2.37M | Nieuw | $156.61M | 0.6% | New | 1 | SEC ↗ |
| 6 | Norges Bank ✦ (passief) | 1.68M | -20.8% | $111.25M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Marshall Wace ✦ | 1.28M | +3711.1% | $84.50M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 1.11M | -10.1% | $73.28M | 0.1% | ▼ Trim | 2 | SEC ↗ ×2 |
| 9 | Citadel Advisors ✦ | 781.28K | -4.9% | $51.64M | 0.1% | ▼ Trim | 2 | SEC ↗ ×2 |
| 10 | T. Rowe Price ✦ | 608.44K | +170.3% | $40.22M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 11 | Millennium Management ✦ | 565.19K | +34.5% | $37.36M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Bridgewater Associates ✦ | 308.63K | +142.8% | $20.40M | 0.1% | ▲ Add | 2 | SEC ↗ |
| 13 | ARK Investment Management ✦ | 211.54K | -46.9% | $13.98M | 0.1% | ▼ Trim | 2 | SEC ↗ |
| 14 | Wellington Management ✦ | 71.73K | -59.0% | $4.74M | 0.0% | ▼ Trim | 2 | SEC ↗ ×2 |
| 15 | Gotham Asset Management ✦ | 65.39K | -18.4% | $4.32M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 16 | Two Sigma Investments ✦ | 20.58K | -90.6% | $1.36M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 17 | Fisher Asset Management ✦ | 11.52K | +24.4% | $761,603 | 0.0% | ▲ Add | 2 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Point72 Asset Management | $156.61M | 0.6% |
Verlaten
| Capital World Investors | $24.01M | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 805 houders, 201.47M aandelen, $18.13B gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.
Open-market aankopen (P)
Geen open-market insider-aankopen in ons dekkingsvenster.
Open-market verkopen (S)
Officer · 2.64K aand · $297,780
Officer · 13.98K aand · $1.69M
Officer · 9.23K aand · $1.11M
Officer · 10.80K aand · $1.36M
Officer · 10.80K aand · $1.30M
Toekenningen, uitoefeningen en belastinginhoudingen worden hier nooit meegeteld als aankopen of verkopen. Methodologie